Latest News and Press Releases

Marchio CE per due tecnologie pionieristiche di MeMed: il test MeMed BV™ e la piattaforma diagnostica MeMed Key™  Una piattaforma strumentale all’avanguardia e un nuovo signature test sulla...

MeMed erhält CE-Kennzeichnung für zwei wegweisende Technologien: den MeMed BV™-Test und die MeMed Key™ Point-of-Need-Plattform Hochmoderne Instrumentenplattform und neuartiger Signaturtest für...

MeMed Receives CE Mark for Two Pioneering Technologies: The MeMed BV™ Test and MeMed Key™ Point-of-Need Platform Cutting-edge instrument platform and a novel host-immune response signature test...

Less invasive approach provides hope for the millions of patients that suffer from leaky mitral valves VANCOUVER and MINNEAPOLIS, MN, May 27, 2020 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE...

SAN CARLOS, Calif., Oct. 08, 2019 (GLOBE NEWSWIRE) -- BioCardia (Nasdaq: BCDA), a leader in the development of comprehensive solutions for cardiovascular regenerative therapies, today announced...

LAFOX, Ill., Sept. 11, 2019 (GLOBE NEWSWIRE) -- Richardson Healthcare, a Division of Richardson Electronics, Ltd. (NASDAQ: RELL), announced today it has received CE Mark approval for the ALTA750®...

FARMINGDALE, N.Y., Aug. 12, 2019 (GLOBE NEWSWIRE) -- Misonix, Inc. (NASDAQ: MSON) (“Misonix” or the “Company”), a provider of minimally invasive therapeutic ultrasonic medical devices that enhance...

NANOBIOTIX ANNONCE LA TOUTE PREMIERE AUTORISATION DE MISE SUR LE MARCHÉ EUROPEEN D’UN RADIOENHANCER Hensify®(NBTXR3) a reçu une autorisation de mise sur le marché (Marquage CE) en Europe...

NANOBIOTIX ANNOUNCES FIRST EVER RADIOENHANCER TO RECEIVE EUROPEAN MARKET APPROVAL Hensify®(NBTXR3) received European market approval (CE mark) enabling commercialization in 27 European Union...

NEW YORK, Oct. 17, 2018 (GLOBE NEWSWIRE) -- PAVmed Inc. (Nasdaq: PAVM, PAVMZ) (the “Company” or “PAVmed”), a highly differentiated, multiproduct medical device company, today provided an update on...